Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2012 Aug;97(8):e26; author reply e27.
doi: 10.3324/haematol.2012.067934.

Infliximab therapy in hematologic malignancies: handle with care

Fabio Stagno, Paolo Vigneri, Alessandra Cupri, Silvia Rita Vitale, Francesco Di Raimondo
Comment

Infliximab therapy in hematologic malignancies: handle with care

Fabio Stagno et al. Haematologica. 2012 Aug.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Baron F, Suciu S, Amadori S, Muus P, Zwierzina H, Denzlinger C, et al. Value of infliximab (Remicade®) in patients with low-risk myelodysplastic syndrome: final results of randomized phase II trial (EORTC trial 06023) of the EORTC Leukemia Group. Haematologica. 2012;97(4):529–33. - PMC - PubMed
    1. Brown SL, Greene MH, Gershon SK, Edwards ET, Braun MM. Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reprted to the Food and Drug Administration. Arthritis Rheum. 2002;46(12):3151–8. - PubMed
    1. Bakland G, Nassent H. Acute myelogenous leukemia following etanercept therapy. Rheumatology. 2003;42(7):900–1. - PubMed
    1. Broussais F, Kawashima M, Marotte H, Miossec P. Chronic myeloid leukemia and tuberculosis in a patient with rheumatoid arthritis treated with infliximab. Ann Rheum Dis. 2005;64(3):509–10. - PMC - PubMed
    1. Fidder H, Schnitzler F, Ferrante M, Noman M, Katsanos K, Segaert S, et al. Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study. Gut. 2009;58(4):501–8. - PubMed

Substances